Glucotrack issues strategic update: LT-100 clinical study targeted, ai² platform expands university network

Glucotrack provided a strategic update highlighting near-term LT-100 clinical plans and growth of its ai² discovery and talent platform.Key Highlights:Original SEC Filing: Glucotrack, Inc. [ GCTK ] - 8-K - Sep. 23, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying i…